PLI Scheme: Strengthening India's Manufacturing Ecosystem & Deepening Localization (See 'Corp Brief') India's Sovereign AI Models must be leveraged to strengthen Ayush digital ecosystem (See 'Corp Brief') Farm-Level AI Deployment in India Can Create Valuable Global Spillover Learnings (See 'Corp Brief') Chouhan issues directions to make MSP Procurement more Robust and Timely (See 'Corp Brief') Leaders Call for Affordable, Easy-to-Use and Multilingual AI for Wider Access (See 'Corp Brief') India, Brazil strengthen Telecom and Digital Partnership (See 'Corp Brief') ICAR, Dr. Reddy's Foundation ink MoU to strengthen agricultural skills & improve rural livelihoods (See 'Corp Brief') Baramati Copter accident: An update (See 'Corp Brief') India-New Zealand hold Working Group Meeting on Horticulture Cooperation (See 'Corp Brief') SARFAESI - Sec 34 bars civil courts from entertaining suits in respect of any action taken or to be taken under SARFAESI Act, and DRT alone has jurisdiction to adjudicate challenges to measures u/s 13(4): HC (See 'Legal Desk') Google CEO Pichai visits Bharat GI Coffee Lounge (See 'Corp Brief') New Delhi Frontier AI Commitments aim to democratize AI Access and Innovation (See 'Corp Brief') India aspires to establish equitable maritime order based on international rules (See 'Corp Brief') A&C - At Section 11 stage, it is required only to examine existence of arbitration agreement and not to adjudicate upon issues of arbitrability or merits, which are to be decided by arbitral tribunal: HC (See 'Legal Desk') Scaling Impactful AI Use Cases critical for India to become 'Use-Case Capital' (See 'Corp Brief') Joshi visits Exhibition on AI-Driven Transformation of Public Distribution System (See 'Corp Brief') IBC - Resolution Professional is obligated to ensure that resolution plan complies with all provisions of law, and he cannot escape liability by claiming lack of available data: HC (See 'Legal Desk') Responsible and Equitable Scaling of AI in Classrooms emerges as Key Priority (See 'Corp Brief') Power Minister inaugurates Pavilion at AI Impact Summit 2026 (See 'Corp Brief') Trade Marks - Section 35 permits bona fide use of one's own name or that of a predecessor in business, even if such use may otherwise amount to infringement under Section 29(5): HC (See 'Legal Desk') CCI approves proposed Merger of Hinduja Leyland Finance into NDL Ventures (See 'Corp Brief') IICA renews MoU with NALSAR to strengthen Academic Collaboration (See 'Corp Brief') Trade Marks - Mere knowledge of respondents' registered trade mark or speculative potential for confusion in tenders cannot negate bona fide adoption where trade name is derived from the predecessor's own surname: HC (See 'Legal Desk') CCI approves acquisition of portfolio services of Axis Securities by Axis Asset Management (See 'Corp Brief') IBC - In real estate projects, single insolvency petition is maintainable against more than one corporate entity if they are intrinsically connected in execution and marketing of project: SC (See 'Legal Desk') Finland-India Synergy can provide strong foundation for co-innovation: Finnish PM (See 'Corp Brief') PMLA - If Enforcement Directorate establishes connection between alleged predicate offences and accumulation or layering of assets, Adjudicating Authority's confirmation of provisional attachment may be upheld: SAFEMA (See 'Legal Desk') Chouhan calls for Direct Farmer Feedback to strengthen Scheme Effectiveness (See 'Corp Brief') PMLA - If under-construction property was purchased using funds routed through shell entities, and neither shares are allotted nor executed any loan agreement, such transaction was benami transaction: SAFEMA (See 'Legal Desk') AI Compendia to serve as Guidebooks for Global South: Govt (See 'Corp Brief') SEBI - Noticee is prohibited from taking up any new clients as stock broker: SEBI (See 'Legal Desk') Supreme Court Clears Path For Single Insolvency Proceedings Against Linked Group Companies (See CORP EINSICHT) IBC - Spectrum allocated to Telecom Service Providers cannot be subjected to proceedings under Insolvency and Bankruptcy Code: SC (See 'Legal Desk') AI is meant to augment, Not replace Clinicians: MoS (See 'Corp Brief') Misc - Delay in filing appeal u/s 74 of Right to Fair Compensation and Transparency in Land Acquisition, Rehabilitation and Resettlement Act, 2013 can be condoned u/s 5 of Limitation Act: SC (See 'Legal Desk') Chouhan launches artificial intelligence-based scheme 'Bharat VISTAAR' Phase 1 in Rajasthan (See 'Corp Brief') A&C - Section 29A does not impose any statutory bar on courts extending mandate after arbitral award has been delivered: SC (See 'Legal Desk') NHAI to develop First of its Kind 'Bee Corridors' along National Highways (See 'Corp Brief') A&C - Parties cannot be compelled to arbitrate when very existence of contract containing arbitration clause was alleged to be fake: SC (See 'Legal Desk') AI to power India's global knowledge leadership, key to Viksit Bharat 2047: Pradhan (See 'Corp Brief') NI Act - Person who is in charge of affairs of conduct of company is vicariously liable for offence u/s 138 of NI Act when cheque issued by company gets dishonoured: SC (See 'Legal Desk') AI and Data Centres are one of Defining Energy Challenges of Our Time (See 'Corp Brief') A&C - Court exercising appellate jurisdiction u/s 37 cannot substitute its own assessment of compensation once Sec 34 court has fixed reasonable award within terms of contract: SC (See 'Legal Desk') Robust and High-Quality Data key to Advanced AI Deployment in Banking and Finance (See 'Corp Brief') A&C - Different interpretation of contract by in itself is no ground to interfere with arbitral award: SC (See 'Legal Desk') India AI Impact Summit 2026 showcases Women-led AI for Public Good (See 'Corp Brief') A&C - Non-issuance of a Sec 21 notice by one party is not fatal to raising claims before arbitral tribunal if disputes are otherwise covered by broadly worded arbitration clause: SC (See 'Legal Desk')

Print

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.